| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | BECTON DICKINSON & CO | 25,000 | 3,796,000 | 0.75% | ||
| 52 | LivaNova PLC | 70,000 | 3,779,000 | 0.75% | ||
| 53 | ENDOLOGIX INC | 435,000 | 3,637,000 | 0.72% | ||
| 54 | HORIZON PHARMA PLC | 200,000 | 3,314,000 | 0.66% | ||
| 55 | RADIUS HEALTH INCORPORATED COM NEW | 105,000 | 3,301,000 | 0.66% | ||
| 56 | INTRA-CELLULAR THERAPIES INC | 115,000 | 3,197,000 | 0.63% | ||
| 57 | Heartware International, Inc. | 100,000 | 3,142,000 | 0.62% | ||
| 58 | OMNICELL INC | 110,000 | 3,066,000 | 0.61% | ||
| 59 | LION BIOTECHNOLOGIES INC COM | 600,000 | 3,048,000 | 0.61% | ||
| 60 | CEMPRA INC | 171,000 | 2,996,000 | 0.59% | ||
| 61 | REVANCE THERAPEUTICS INC COM | 170,000 | 2,968,000 | 0.59% | ||
| 62 | DYNAVAX TECHNOLOGIES CORP | 150,000 | 2,886,000 | 0.57% | ||
| 63 | INSULET CORPORATION | 82,000 | 2,719,000 | 0.54% | ||
| 64 | XENCOR INC COM | 200,000 | 2,684,000 | 0.53% | ||
| 65 | EXELIXIS INC | 650,000 | 2,600,000 | 0.52% | ||
| 66 | IONIS PHARMACEUTICALS INC COM | 64,000 | 2,592,000 | 0.51% | ||
| 67 | CHIMERIX INC | 500,000 | 2,555,000 | 0.51% | ||
| 68 | Esperion Therapeutics Inc | 150,000 | 2,537,000 | 0.50% | ||
| 69 | ULTRAGENYX PHARMACEUTICAL INC COM | 40,000 | 2,532,000 | 0.50% | ||
| 70 | FIBROGEN INC | 114,000 | 2,427,000 | 0.48% | ||
| 71 | NEUROCRINE BIOSCIE COM USD0.001 | 60,000 | 2,373,000 | 0.47% | ||
| 72 | MACROGENICS INC | 120,000 | 2,250,000 | 0.45% | ||
| 73 | PORTOLA PHARMACEUTICALS INC | 105,000 | 2,142,000 | 0.43% | ||
| 74 | PACIRA PHARMACEUTICALS INC | 40,000 | 2,119,000 | 0.42% | ||
| 75 | HOLOGIC INC | 60,000 | 2,070,000 | 0.41% | ||
| 76 | ACHILLION PHARMACEUTICALS IN | 266,000 | 2,054,000 | 0.41% | ||
| 77 | TANDEM DIABETES CARE INC COM | 209,000 | 1,820,000 | 0.36% | ||
| 78 | RIGEL PHARMACEUTICAL INC | 850,000 | 1,768,000 | 0.35% | ||
| 79 | Catabasis Pharmaceuticals Inc | 345,100 | 1,739,000 | 0.35% | ||
| 80 | ANTHERA PHARMACEUTICALS I | 435,000 | 1,575,000 | 0.31% | ||
| 81 | ACADIA PHARMACEUTICALS INC COM | 50,000 | 1,398,000 | 0.28% | ||
| 82 | TETRAPHASE PHARMACEUTICALS INC COM | 300,000 | 1,389,000 | 0.28% | ||
| 83 | REGULUS THERAPEUTICS INC COM | 200,000 | 1,386,000 | 0.28% | ||
| 84 | VALEANT PHARMACEUTICALS INTL | 50,000 | 1,315,000 | 0.26% | ||
| 85 | NEVRO CORP COM | 20,000 | 1,125,000 | 0.22% | ||
| 86 | ARRAY BIOPHARMA INC | 370,000 | 1,092,000 | 0.22% | ||
| 87 | MIRATI THERAPEUTICS INC COM | 50,000 | 1,070,000 | 0.21% | ||
| 88 | AVALANCHE BIOTECHNOLOGIES IN | 154,006 | 796,000 | 0.16% | ||
| 89 | OREXIGEN THERAPEUTICS INC COM | 1,200,000 | 675,000 | 0.13% | ||
| 90 | OCULAR THERAPEUTIX INC | 40,000 | 386,000 | 0.08% | ||
| 91 | BIND THERAPEUTICS INC | 133,535 | 294,000 | 0.06% | ||
| 92 | THRESHOLD PHARMACEUTICAL INC | 201,537 | 93,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-005562, filed 2016.04.19).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
